LHDX News and Press, Lucira Health Inc. From 05/12/21

Second Sight Medical Products (EYES) +24% on reporting two-year results of its Orion study.Upstart Holdings (UPST) +23% on Q1 results.Minerva Neurosciences (NERV) +23% on Q1 results.fuboTV Inc. (FUBO) +21% on Q1 results.Biomerica (BMRA) +17%.Lucira Health (LHDX) +16% ...

This FDA EUA first and only PCR quality, single-use, COVID-19 at home, self-test kit is available for $55 to all Amazon US customers Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative...

EMERYVILLE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, tod...

Lucira Health, Inc. (NASDAQ: LHDX) has been one of the most disappointing and wildest IPOs in recent memory. On Feb. 5, the coronavirus testmaker went public at $17 and soared to a high watermark of $38 per share. Shortly after that, however, its momentum stalled. The stock is hover...

EMERYVILLE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, t...

Jabil’s Michigan plant is joined by new Dominican Republic facility Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the opening...

Medical technology company Lucira Health ([[LHDX]] +5.3%) announces that Health Canada has issued an "authorization with conditions" for the LUCIRA CHECK IT COVID-19 test kit. The approval makes Lucira's kit the first self-test authorized by Health Canada for individuals with o...

LUCIRA™ CHECK IT COVID-19 Self-Test Receives Interim Order Authorization Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that H...

Lucira’s lab quality PCR test has FDA OTC (over the counter) clearance for all Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announ...

Lucira Health ([[LHDX]] -18.7%) has extended its pre-market losses even further to drop by double-digit percentage points in the late trading hours after Bank of America downgraded the stock to underperform from neutral.The company’s preliminary Q1 2021 revenue was far below their esti...